Mills Kenneth T.'s Form 4 filing
REGENXBIO Inc. (RGNX) · filed Dec 21, 2023
- Accession no.
- 0001562180-23-008519
- Filed
- Dec 21, 2023
- Trade date
- Dec 19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $886.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mills Kenneth T.CIK 0001652824 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 | Common Stock | MOption exerciseAcquired | +43,500 | $3.76 | +$163,560 | 398,789 | Direct | |
| Dec 19, 2023 | Common Stock | MOption exerciseAcquired | +1,500 | $0.85 | +$1,275 | 400,289 | Direct | |
| Dec 19, 2023 | Common Stock | SSaleDisposed | −45,000 | $19.69 | −$886,050 | 355,289 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2023 | Common Stock | MOption exerciseDisposed | −43,500 | $0.00 | $0 | 186,354 | Direct | |
| Dec 19, 2023 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 36,316 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.